Targeted Therapies - EGFR

You are here

Targeted Therapies - EGFR

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

ASCO 2018 - Combining Metformin with Standard EGFR Therapy - Is the Jury Still Out
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Chemotherapy, Non Small Cell Lung Cancer, Targeted Therapies - EGFR
ASCO 2018 - Tarceva or Tarceva with Avastin as 1st Line for EGFR Positive NSCLC vs. Tagrisso or Vizimpro
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Targeted Therapies - EGFR, First-line treatment
Lung Cancer Video Library - 2017 The Changing Landscape of First Line Treatment for EGFR Mutation-Positive NSCLC
Jack West, MD, President and CEO of GRACE provides updates to our Lung Cancer Video Library. In this recent video, Dr. West discusses the changing landscape of first-line treatment for EGFR mutation-positive non-small cell lung cancer (NSCLC).
Cancer Journey:
Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
First-line treatment, Targeted Therapies - EGFR
ASCO 2017 - Lung Cancer - Improved Progression-Free Survival with Iressa as Adjuvant Therapy for EGFR Patients
Drs. H. Jack West, Matthew Gubens, and Jyoti Patel, gathered post ASCO 2017 to discuss new information regarding lung cancer. In this video, the doctors discuss Improved Progression-Free Survival with Iressa as Adjuvant Therapy for EGFR Mutation Positive Patients.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Targeted Therapies - EGFR
Targeted Therapies in Lung Cancer Patient Forum 2016 - Welcome and Keynote 1
On August 20, 2016, in collaboration with the University of Colorado Cancer Center, GRACE presented the Targeted Therapies in Lung Cancer Patient Forum in Aurora Colorado. We are happy to share the videos from this live and webcast forum. Our first video welcomes all to the event, and it was our extreme pleasure to have Chris Draft and Dr. Ross Camidge join us to start the day! This is followed by keynote topic "Does NED matter? Using “curative” surgery or radiation techniques to treat "incurable" advanced lung cancer," with Dr. Rob Meguid, and a panel discussion featuring Dr. Meguid, Dr. Chad Rusthoven, Dr. Ross Camidge, and chaired by Dr. H. Jack West.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Targeted Therapy, Molecular Testing

Articles

Registration is Now Open for the 2019 Targeted Therapies Live Patient Forum
Register Now for the Targeted Therapies Patient Forum Join our faculty April 6, 2019, in Philadelphia, PA to learn about the newest breakthroughs in...
Cancer Journey:
Just Diagnosed, In Treatment, In Remission, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1
Direct Comparison of 2 EGFR Inhibitors Shows There Are Clinically Significant Differences
Fast forward 1.5 years, and we now have the early results of LUX-Lung-7, and they show that these EGFR TKIs are not completely interchangeable...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, First-line treatment, Targeted Therapies - EGFR

Community Forum

Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?
Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Drugs, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Procedures & Treatments, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Investigational Agents, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Progression on Tarceva - T790m negative
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Molecular Testing, Immunotherapies, Non Small Cell Lung Cancer
Can Tagrisso be used in additional to Alimta maintenance
My wife was on Tarceva for over 6 1/2 years. Then she developed acquired resistance to Tarceva with prevascular and supraclevical lymph nodes...
Cancer Journey:
Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies - EGFR, Biopsy/Tissue Collection, Maintenance Therapy, Non Small Cell Lung Cancer
Tagrisso for acquired resistance to Tarceva
My wife has come a long way with Stage IV lung cancer since 2010. She has now developed acquired resistance to Tarceva. Gene sequence of biopsy from...
Cancer Journey:
Just Diagnosed, In Treatment, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Non Small Cell Lung Cancer
Targeted therapy for Exon20
Hi Grace community, Thank you for the extensive information and great support on your website. It seems that after 9,5 years I have developed...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies - EGFR, Immunotherapies